The lower prices stem from the Medicare negotiation program created under the Biden administration’s Inflation Reduction Act.
The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy.
The price cuts come through the Medicare drug price negotiation program created under the Inflation Reduction Act, which Joe Biden signed into law in 2022.
It’s different from Donald Trump’s “most favored nation” drug pricing approach, which relies on executive orders and voluntary deals with drugmakers — not legislation. Trump recently announced such a deal with Novo Nordisk, the maker of Ozempic and Wegovy, to lower the price of the drugs in exchange for tariff relief.
You don’t want to eat more when you taking a glp1.
They’re one of the few drugs that seem to actually address overeating disorders that people have been unable to manage through other means.